|
|
We Have Recently Made Changes to Our Website, If you are unable to find something Specific, Please Search Below
Publish Date : 9/9/2004 3:32:00 PM Source : SkinCareIndia Health News A study designed to reduce the levels of indoor allergens – conducted in the homes of inner-city children with asthma – resulted in fewer asthma exacerbations and unscheduled visits for asthma during a two-year period.
According to a UT Southwestern Medical Center at Dallas researcher who participated in the multicenter study. The National Institutes of Health study, reported in today's The New England Journal of Medicine, showed that an environmental intervention designed to reduce allergen levels in the home indeed led to a marked reduction of irritants. As a result, children living in these homes had fewer problems with their asthma "Indoor allergens play an important role in the asthma severity in these children," said Dr. Rebecca Gruchalla, chief of allergy at UT Southwestern and a study author. "We can't just focus on medications. We must also focus on allergen triggers in the home and work with caretakers to decrease or even eliminate these allergens." Researchers followed more than 900 children ages 5 to 11 with asthma who live in inner-city areas in New York City, Boston, Chicago, Dallas, Seattle/Tacoma, Wash., and Tucson, Ariz. Research teams went to individual households and initiated measures to decrease levels of dust mite, cockroach, dog, cat, rat, mouse and mold allergens. An additional focus was on tobacco smoke. Caretakers were educated about how to perform the various intervention strategies themselves. Asthma, a chronic lung disease, affects about 20 million Americans. Inner-city children suffer disproportionately from the disease, primarily because of exposure to high levels of multiple indoor allergens and tobacco smoke. "These study results are exciting because they show that changes made in the home environment can produce a reduction in symptoms comparable to that achieved with asthma inhalers," said Dr. Kenneth Olden, director of the National Institute of Environmental Health Sciences. Children who participated in the intervention had 21 fewer days of symptoms than the control group in the first year and an average of 16 fewer days during the second, follow-up year. "We wanted this to have a long-term impact, not just for the duration of the study," Dr. Gruchalla said. "In many cases, we taught them simple cleaning measures to decrease the roach population – things like not leaving food uncovered and caulking obvious cracks in the wall." Interventions also included encasing the child's mattress, springs and pillow in allergen-impermeable covers; repairing water leaks; and removing carpet from the bedroom, if possible. Families were also given HEPA (high efficiency particulate air) filters. Cockroach extermination visits were provided in homes where children were sensitive to that allergen. The suggestions were typically well-received, Dr. Gruchalla said. Study participants had suffered at least one asthma-related hospitalization or two asthma-related unscheduled doctor visits the six months prior to enrollment in the study. They also had a positive allergy skin test to at least one of 11 indoor allergens such as dust mites, molds, cockroaches, pets or rodents. Researchers performed a baseline clinical evaluation, including questionnaires on asthma symptoms, medication use and the home environment. Later, researchers made a baseline home evaluation by visually inspecting and collecting dust from the child's bedroom. The families were then taught how to reduce allergens in their homes, told why it was necessary and given the needed tools to accomplish the task. Researchers followed up by phone and collected information about the child's asthma every few months during the intervention year and one year after. The project was part of the Inner City Asthma Study, a multicenter study comprising six asthma centers – in addition to UT Southwestern – across the country and a statistical center, including the University of Arizona College of Medicine; Albert Einstein College of Medicine of Yeshiva University/Jacobi Medical Center; Boston University School of Medicine; Mount Sinai School of Medicine of New York University; Children's Memorial Hospital in Chicago; the University of Washington School of Medicine and Public Health; and Rho Inc. in Chapel Hill, N.C. To automatically receive news releases from UT Southwestern via e-mail, subscribe at |
|
Cervical cancer vaccine breakthrough
Publish Date : 11/15/2004 1:16:00 PM Scientists say they have tested a vaccine, Cervarix, that protects women from two strains of HPV (human papillomavirus) which are responsible for 70% of cervical cancers. Beyond Tactical Struggles over Public Policy -The President's Council on Bioethics Publish Date : 11/15/2004 1:15:00 PM An on-stage discussion with William F May, PhD. Bioethicist and Author Human mad cow disease, there are many different forms of it Publish Date : 11/15/2004 1:15:00 PM Depending on your genetic makeup, vCJD (Varian Mad Cow Disease) will manifest itself differently, say researchers. This means vCJD may be present in some areas without being detected (vCJD means the human form of mad cow disease). New online tool kit on HIV/AIDS prevention for sex workers Publish Date : 11/15/2004 1:11:00 PM GTZ, WHO and sex work networks share information and lessons learned - The German technical cooperation (GTZ) and the World Health Organization (WHO), in collaboration with sex work networks around the world..... Anti-drug driving campaign wins award Publish Date : 11/10/2004 7:34:00 PM A road safety initiative to stop people driving under the influence of drugs has won an award at the THINK road safety conference. Text Messaging Helps Patients in Developing Countries Manage HIV/AIDS Treatment Publish Date : 11/10/2004 7:33:00 PM Wired News on Thursday examined how HIV/AIDS treatment counselors in countries where health care .... Roche Diagnostics Launches Highly-sensitive Polymerase Chain Reaction System Publish Date : 11/10/2004 7:32:00 PM Roche Diagnositcs has begun sales of it's real-time polymerase chain reaction (PCR) system LightCycler ST300, a highly-sensitive gene analysis system. 3 by 5 Initiative for HIV 'Probably Will Not' Meet Treatment Publish Date : 11/10/2004 7:31:00 PM The World Health Organization's 3 by 5 Initiative goal of treating three million HIV-positive people with antiretroviral ........ Manufacturing Approval for Statmark Influenza Virus Detection Reagent Publish Date : 11/10/2004 7:30:00 PM Nichirei (TSe: 2871), a leading Japanese food processing company, has announced that it has ..... US Health Improvements Slowing - Alarm at High Infant Mortality Rates and Obesity Publish Date : 11/10/2004 7:28:00 PM Although the overall health of US residents continues to improve, health indicators show that ... Total Results : 3044 More News (Opens in New Window) : [1] 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 Next Page |
|